1. Rubio-Tapia A., Hill I.D., Semrad C. et al. American College of Gastroenterology Guidelines Update: Diagnosis and Management of Celiac Disease. Am J Gastroenterol. 2023;118(1):59–76. DOI: 10.14309/ajg.0000000000002075
2. Lebwohl B., Rubio-Tapia A. Epidemiology, Presentation, and Diagnosis of Celiac Disease. Gastroenterology. 2021;160(1):63–75. DOI: 10.1053/j.gastro.2020.06.098
3. Al-Toma A., Zingone F., Branchi F. et al. European Society for the Study of Coeliac Disease 2025 Updated Guidelines on the Diagnosis and Management of Coeliac Disease in Adults. Part 1: Diagnostic Approach. United European Gastroenterol J. 2025;13(10):1855–1886. DOI: 10.1002/ueg2.70119
4. Антишин А.С., Полищук А.Р., Манина М.А. и др. Популяционное исследование распространенности целиакии среди школьников г. Москвы. Вопросы детской диетологии. 2023;21(2):13–23. DOI: 10.20953/1727-5784-2023-2-13-23. Antishin A.S., Polishchuk A.R., Manina M.A. et al. Population-based study of the prevalence of celiac disease among schoolchildren in Moscow. Pediatric Nutrition. 2023;21(2):13–23 (in Russ.). DOI: 10.20953/1727-5784-2023-2-13-23
5. Аверкина Н.А., Баранов А.А., Бельмер С.В. и др. «Целиакия-2025»: проект клинических рекомендаций по диагностике и лечению целиакии у детей. Педиатрическая фармакология. 2025;22(4):495–522. DOI: 10.15690/pf.v22i4.2941. Averkina N.A., Baranov A.A., Bel'mer S.V. et al. "Celiac Disease-2025”: Project of Clinical Guidelines for the Diagnosis and Treatment of Celiac Disease in Children. Pediatric pharmacology. 2025;22(4):495–522 (in Russ.). DOI: 10.15690/pf.v22i4.2941
6. Бакулин И.Г., Семенова Е.А., Авалуева Е.Б. и др. Клинические портреты пациентов с глютен-ассоциированными заболеваниями (по данным Северо-Западного центра лечения пациентов с глютен-ассоциированными заболеваниями). Терапевтический архив. 2025;97(8):696–703. DOI: 10.26442/00403660.2025.08.203362. Bakulin I.G., Semenova E.A., Avalueva E.B. et al. Clinical portraits of patients with gluten-associated diseases (according to the North-West Center for the Treatment of Patients with Gluten-Associated Diseases). Ter Arkh. 2025;97(8):696–703 (in Russ.). DOI: 10.26442/00403660.2025.08.203362
7. Бакулин И.Г., Авалуева Е.Б., Хавкин А.И. и др. Глютен-ассоциированные заболевания: современные представления о проблеме. Часть 1. Вопросы практической педиатрии. 2021;16(6):103–110. DOI: 10.20953/1817-7646-2021-6-103-1108. Bakulin I.G., Avalueva E.B., Khavkin A.I. et al. Gluten-related disorders: current concepts. Part 1. Clinical Practice in Pediatrics. 2021;16(6):103–110 (in Russ.). DOI: 10.20953/1817-7646-2021-6-103-110
8. Rouvroye M.D., Roos A., Bergkamp F. et al. The frequency of HLA-DQ7 in patients at risk of coeliac disease: A haplotype to be reckoned with for screening? Hum Immunol. 2024;85(6):111158. DOI: 10.1016/j.humimm.2024.111158
9. Кондратьева Е.И., Янкина Г.Н., Лошкова Е.В. Целиакия в свете синтропных заболеваний и генов. В кн.: Целиакия у детей. Под ред. С.В. Бельмера, М.О. Ревновой. 2-е изд., перераб. и доп. М.: ИД «МЕДПРАКТИКА-М»; 2020:51–71. Kondratyeva E.I., Yankina G.N., Loshkova E.V. Celiac disease in the context of syntropic diseases and genes. In: Belmer S.V., Revnova M.O., editors. Celiac disease in children. 2nd ed. Moscow: MEDPRACTIKA-M Publishing House; 2020:51–71 (in Russ.).
10. Karimzadhagh S., Abbaspour E., Ghodous S. et al. Global Prevalence and Clinical Manifestations of Celiac Disease Among First-Degree Relatives: A Systematic Review and Meta-Analysis. Am J Gastroenterol. 2024;120(7):1488–1501. DOI: 10.14309/ajg.0000000000003227
11. Bielik M., Selvek M., Suchánkova M., Shawkatova I. A case-control epidemiological survey on potential risk factors for celiac disease. Cent Eur J Public Health. 2024;32(2):119–124. DOI: 10.21101/cejph.a8010
12. Zingone F., Baiet J.C., Cellier C., Ludvigsson J. Celiac Disease-Related Conditions: Who to Test? Gastroenterology. 2024;167(1):64–78. DOI: 10.1053/j.gastro.2024.02.044
13. Flores Monar G.V., Islam H., Puttagunta S.M. et al. Association Between Type 1 Diabetes Mellitus and Celiac Disease: Autoimmune Disorders With a Shared Genetic Background. Cureus. 2022;14(3):e22912. DOI: 10.7759/cureus.22912
14. Pobłocki J., Pańka T., Szczuko M. et al. Whether a Gluten-Free Diet Should Be Recommended in Chronic Autoimmune Thyroiditis or Not? - A 12-Month Follow-Up. J Clin Med. 2021;10(15):3240. DOI: 10.3390/jcm10153240
15. Ashok T., Patni N., Fatima M. et al. Celiac Disease and Autoimmune Thyroid Disease: The Two Peas in a Pod. Cureus. 2022;14(6):e26243. DOI: 10.7759/cureus.26243
16. Malandrini S., Trimboli P., Guzzaloni G. et al. What about TSH and Anti-Thyroid Antibodies in Patients with Autoimmune Thyroiditis and Celiac Disease Using a Gluten-Free Diet? A Systematic Review. Nutrients. 2022;14(8):1681. DOI: 10.3390/nu14081681
17. Hua L., Xiang S., Xu R. et al. Causal association between rheumatoid arthritis and celiac disease: A bidirectional two-sample mendelian randomization study. Front Genet. 2022;13:976579. DOI: 10.3389/fgene.2022.976579
18. Mårild K., Söderling J., Lebwohl B. et al. Association of Celiac Disease and Inflammatory Bowel Disease: A Nationwide Register-Based Cohort Study. Am J Gastroenterol. 2022;117(9):1471–1481. DOI: 10.14309/ajg.0000000000001834
19. Pinto-Sanchez M.I., Seiler C.L., Santesso N. et al. Association Between Inflammatory Bowel Diseases and Celiac Disease: A Systematic Review and Meta-Analysis. Gastroenterology. 2020;159(3):884–903.e31. DOI: 10.1053/j.gastro.2020.05.016
20. Yoosuf S., Singh P., Khaitan A. et al. Prevalence of Celiac Disease in Patients With Liver Diseases: A Systematic Review and Meta-Analyses. Am J Gastroenterol. 2023;118(5):820–832. DOI: 10.14309/ajg.0000000000002123
21. Haggård L., Glimberg I., Lebwohl B. et al. High prevalence of celiac disease in autoimmune hepatitis: Systematic review and meta-analysis. Liver Int. 2021;41(11):2693–2702. DOI: 10.1111/liv.15000
22. Zingone F., Canova C., Forss A. et al. Prevalence of Celiac Disease in Patients With Primary Biliary Cholangitis: A Systematic Review and Meta-Analysis. Liver Int. 2025;45(9):e70293. DOI: 10.1111/liv.70293
23. Balaban D.V., Mihai A., Dima A. et al. Celiac disease and Sjögren's syndrome: A case report and review of literature. World J Clin Cases. 2020;8(18):4151–4161. DOI: 10.12998/wjcc.v8.i18.4151
24. AlEnzi F., Yateem M., Shaikh M. et al. The Value of Screening for Celiac Disease in Systemic Lupus Erythematosus: A Single Experience of a Tertiary Medical Center. Rheumatol Ther. 2020;7(3):649–656. DOI: 10.1007/s40744-020-00223-6
25. Lebwohl B., Green P.H.R., Söderling J. et al. Association Between Celiac Disease and Mortality Risk in a Swedish Population. JAMA. 2020;323(13):1277–1285. DOI: 10.1001/jama.2020.1943
26. Akkurt Kocaeli A., Cander S., Gül Ö.Ö. et al. Serological Screening for Celiac Disease and Gastrointestinal Absorption Disorders in Patients with Autoimmune Endocrine Diseases. Horm Metab Res. 2023;55(11):781–787. DOI: 10.1055/a-2156-2773
27. Опрятин Л.А. Глютен-ассоциированные заболевания кожи у детей: автореф. дисс. … канд. мед. наук. М.; 2023. Opryatin L.A. Gluten-associated skin diseases in children: thesis. Moscow: 2023 (in Russ.).
28. Hadjivassiliou M., Grϋnewald R.A. Gluten Ataxia: an Underdiagnosed Condition. Cerebellum. 2022;21(4):620–622. DOI: 10.1007/s12311-021-01270-7
29. Опрятин Л.А. Атопический дерматит и целиакия как коморбидные состояния в детской дерматологии. Медицинский алфавит. 2022;(8):86–88. DOI: 10.33667/2078-5631-2022-8-86-88. Opryatin L.A. Atopic dermatitis and celiac disease as comorbid conditions in pediatric dermatology. Medical alphabet. 2022;(8):86–88 (in Russ.). DOI: 10.33667/2078-5631-2022-8-86-88
30. Edalatkhah R., Aflatooninan M., Dehghani Firouzabadi B. et al. Evaluation of Frequency of Celiac Disease in Children with Idiopathic Epilepsy. Iran J Child Neurol. 2024;18(4):61–70. DOI: 10.22037/ijcn.v18i1.36844
31. Du Y., Shan L.F., Cao Z.Z. et al. Prevalence of celiac disease in patients with Down syndrome: a meta-analysis. Oncotarget. 2017;9(4):5387–5396. DOI: 10.18632/oncotarget.23624
32. Al-Bluwi G.S.M., AlNababteh A.H., Östlundh L. et al. Prevalence of Celiac Disease in Patients With Turner Syndrome: Systematic Review and Meta-Analysis. Front Med (Lausanne). 2021;8:674896. DOI: 10.3389/fmed.2021.674896
33. Ghisleni C., Parma B., Cianci P. et al. Celiac disease prevalence and predisposing-HLA in a cohort of 93 Williams-Beuren syndrome patients. Am J Med Genet A. 2023;191(1):84–89. DOI: 10.1002/ajmg.a.62990
34. Tanpowpong P., Li S., Espinola J.A. et al. Pregnancy- and birth-related risk factors for the development of childhood celiac disease. Acta Paediatr. 2023;112(5):1029–1034. DOI: 10.1111/apa.16686
35. Lionetti E., Castellaneta S., Francavilla R. et al. Introduction of gluten, HLA status, and the risk of celiac disease in children. N Engl J Med. 2014;371(14):1295–303. DOI: 10.1056/NEJMoa1400697
36. Andrén Aronsson C., Lee H.S., Hård Af Segerstad E.M. et al. TEDDY Study Group. Association of Gluten Intake During the First 5 Years of Life With Incidence of Celiac Disease Autoimmunity and Celiac Disease Among Children at Increased Risk. JAMA. 2019;322(6):514–523. DOI: 10.1001/jama.2019.10329
37. Auricchio R., Calabrese I., Galatola M. et al. Gluten consumption and inflammation affect the development of celiac disease in at-risk children. Sci Rep. 2022;12(1):5396. DOI: 10.1038/s41598-022-09232-7. Erratum in: Sci Rep. 2022;12(1):8157. DOI: 10.1038/s41598-022-12636-0
38. Dydensborg Sander S., Nybo Andersen A.M., Murray J.A. et al. Association Between Antibiotics in the First Year of Life and Celiac Disease. Gastroenterology. 2019;156(8):2217–2229. DOI: 10.1053/j.gastro.2019.02.039
39. Lebwohl B., Spechler S.J., Wang T.C. et al. Use of proton pump inhibitors and subsequent risk of celiac disease. Dig Liver Dis. 2014;46(1):36–40. DOI: 10.1016/j.dld.2013.08.128
40. Zhang X., Li Q., Xia S. et al. Proton Pump Inhibitors and Oral-Gut Microbiota: From Mechanism to Clinical Significance. Biomedicines. 2024;12(10):2271. DOI: 10.3390/biomedicines12102271
41. Jang S., Lebwohl B., Abrams J.A. et al. Celiac disease serology and gut microbiome following proton pump inhibitor treatment. Medicine (Baltimore). 2020;99(35):e21488. DOI: 10.1097/MD.0000000000021488. Erratum in: Medicine (Baltimore). 2020;99(42):e22947. DOI: 10.1097/MD.0000000000022947
42. Jordan R., Shannahan S., Lewis S.K. et al. The impact of acid suppression medications and non-steroidal anti-inflammatory drugs on clinical and histologic features in celiac disease. Dig Liver Dis. 2017;49(8):883–886. DOI: 10.1016/j.dld.2017.03.018
43. Sánchez D., Hoffmanová I., Szczepanková A. et al. Contribution of Infectious Agents to the Development of Celiac Disease. Microorganisms. 2021;9(3):547. DOI: 10.3390/microorganisms9030547
44. Hemming-Harlo M., Lähdeaho M.L., Mäki M., Vesikari T. Rotavirus Vaccination Does Not Increase Type 1 Diabetes and May Decrease Celiac Disease in Children and Adolescents. Pediatr Infect Dis J. 2019;38(5):539–541. DOI: 10.1097/INF.0000000000002281
45. Lexner J., Lindroth Y., Sjöberg K. The risk for celiac disease after Covid-19 infection. BMC Gastroenterol. 2023;23(1):174. DOI: 10.1186/s12876-023-02795-3
46. Kahrs C.R., Chuda K., Tapia G. et al. Enterovirus as trigger of coeliac disease: nested case-control study within prospective birth cohort. BMJ. 2019;364:l231. DOI: 10.1136/bmj.l231
47. Tapia G., Chudá K., Kahrs C.R. et al. Parechovirus Infection in Early Childhood and Association With Subsequent Celiac Disease. Am J Gastroenterol. 2021;116(4):788–795. DOI: 10.14309/ajg.0000000000001003
48. Amlashi F.I., Norouzi Z., Sohrabi A. et al. A systematic review and meta-analysis for association of Helicobacter pylori colonization and celiac disease. PLoS One. 2021;16(3):e0241156. DOI: 10.1371/journal.pone.0241156
49. Wijarnpreecha K., Lou S., Panjawatanan P. et al. Cigarette smoking and risk of celiac disease: A systematic review and meta-analysis. United European Gastroenterol J. 2018;6(9):1285–1293. DOI: 10.1177/2050640618786790
50. Xue F., Xue J., Zhao B., Zhu S. The Associations of Tobacco, Alcohol, and Coffee Consumption with Upper and Lower Gastrointestinal Disease Risk: A Mendelian Randomization Study. Gut Liver. 2025;19(5):715–724. DOI: 10.5009/gnl240440